These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

244 related articles for article (PubMed ID: 7931486)

  • 1. Soluble CD23 reliably reflects disease activity in B-cell chronic lymphocytic leukemia.
    Reinisch W; Willheim M; Hilgarth M; Gasché C; Mader R; Szepfalusi S; Steger G; Berger R; Lechner K; Boltz-Nitulescu G
    J Clin Oncol; 1994 Oct; 12(10):2146-52. PubMed ID: 7931486
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cellular expression and serum circulating levels of CD23 in B-cell chronic lymphocytic leukemia. Implications for prognosis.
    Molica S; Levato D; Dell'Olio M; Matera R; Minervini M; Dattilo A; Carotenuto M; Musto P
    Haematologica; 1996; 81(5):428-33. PubMed ID: 8952156
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prognostic importance of soluble CD23 in B-cell chronic lymphocytic leukemia.
    Saka B; Aktan M; Sami U; Oner D; Sanem O; Dinçol G
    Clin Lab Haematol; 2006 Feb; 28(1):30-5. PubMed ID: 16430457
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognostic importance of serum soluble CD23 level in chronic lymphocytic leukemia.
    Sarfati M; Chevret S; Chastang C; Biron G; Stryckmans P; Delespesse G; Binet JL; Merle-Beral H; Bron D
    Blood; 1996 Dec; 88(11):4259-64. PubMed ID: 8943862
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Soluble CD23 and other receptors (CD4, CD8, CD25, CD71) in serum of patients with chronic lymphocytic leukemia.
    Beguin Y; Lampertz S; De Groote D; Igot D; Malaise M; Fillet G
    Leukemia; 1993 Dec; 7(12):2019-25. PubMed ID: 8255102
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serum levels of soluble CD23, but not soluble CD25, predict disease progression in early stage B-cell chronic lymphocytic leukemia.
    Knauf WU; Langenmayer I; Ehlers B; Mohr B; Adorf D; Nerl CH; Hallek M; Zwingers TH; Emmerich B; Thiel E
    Leuk Lymphoma; 1997 Nov; 27(5-6):523-32. PubMed ID: 9477135
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Soluble CD23 measurement by CBA: a convenient and reliable quantification method in chronic lymphocytic leukemia.
    Grelier A; Le Garff-Tavernier M; Nauwelaers F; Sarfati M; Merle-Beral H
    Cytometry B Clin Cytom; 2014 Mar; 86(2):91-7. PubMed ID: 24150841
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The role of soluble CD23 in distinguishing stable and progressive forms of B-chronic lymphocytic leukemia.
    Schwarzmeier JD; Shehata M; Hilgarth M; Marschitz I; Louda N; Hubmann R; Greil R
    Leuk Lymphoma; 2002 Mar; 43(3):549-54. PubMed ID: 12002758
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical significance of sIL2R, sCD23, sICAM-1, IL6 and sCD 14 serum levels in B-cell chronic lymphocytic leukemia.
    Callea V; Morabito F; Luise F; Piromalli A; Filangeri M; Stelitano C; Iacopino P; Nobile F; Brugiatelli M
    Haematologica; 1996; 81(4):310-5. PubMed ID: 8870374
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Proliferative response of B chronic lymphocytic leukemia lymphocytes stimulated with IL2 and soluble CD23.
    Brizard A; Morel F; Lecron JC; Dreyfus B; Brizard F; Barra A; Preud'homme JL
    Leuk Lymphoma; 1994 Jul; 14(3-4):311-8. PubMed ID: 7950920
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lag times between lymphoproliferative disorder and clinical diagnosis of chronic lymphocytic leukemia: a prospective analysis using plasma soluble CD23.
    Kaaks R; Sookthai D; Łuczyńska A; Oakes CC; Becker S; Johnson T; Johansson A; Melin B; Sjöberg K; Trichopoulos D; Trichopoulou A; Lagiou P; Mattiello A; Tumino R; Masala G; Agnoli C; Boeing H; Aleksandrova K; Brennan P; Franceschi S; Roulland S; Casabonne D; de Sanjose S; Sánchez MJ; Huerta JM; Ardanaz E; Sala N; Overvad K; Tjønneland A; Halkjær J; Weiderpass E; Bueno-de-Mesquita HB; Vermeulen R; Peeters PH; Vineis P; Kelly RS; Khaw KT; Travis RC; Key TJ; Riboli E; Nieters A
    Cancer Epidemiol Biomarkers Prev; 2015 Mar; 24(3):538-45. PubMed ID: 25542829
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Phenotypic analysis of receptor-ligand pairs on B-cells in B-chronic lymphocytic leukemia.
    Gagro A; Dasić G; Sabioncello A; Rabatić S; Reckzeh B; Havemann K; Kardum I; Jacksić B; Vitale B
    Leuk Lymphoma; 1997 Apr; 25(3-4):301-11. PubMed ID: 9168440
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serum soluble CD23 levels are an independent predictor of time to first treatment in chronic lymphocytic leukemia.
    Piñeyroa JA; Magnano L; Rivero A; Rivas-Delgado A; Nadeu F; Correa JG; Giné E; Villamor N; Filella X; Colomer D; López M; López-Oreja I; Costa D; Aymerich M; Beà S; López-Guillermo A; Campo E; Delgado J; Mozas P
    Hematol Oncol; 2022 Oct; 40(4):588-595. PubMed ID: 35611996
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinico-prognostic implications of simultaneous increased serum levels of soluble CD23 and beta2-microglobulin in B-cell chronic lymphocytic leukemia.
    Molica S; Levato D; Cascavilla N; Levato L; Musto P
    Eur J Haematol; 1999 Feb; 62(2):117-22. PubMed ID: 10052715
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serum beta(2)-microglobulin and serum thymidine kinase are independent predictors of progression-free survival in chronic lymphocytic leukemia and immunocytoma.
    Hallek M; Wanders L; Ostwald M; Busch R; Senekowitsch R; Stern S; Schick HD; Kuhn-Hallek I; Emmerich B
    Leuk Lymphoma; 1996 Aug; 22(5-6):439-47. PubMed ID: 8882957
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Evolution of chronic lymphocytic leukemia: predictive value of immunophenotype, soluble CD23 and morphology].
    Sarmientó MA; Palacios MF; Scolnik MP; Ramírez FR; Stanganelli C; Cabrera J; Chena CP; Arrossagaray G; Slavutsky IR; Bengió RM
    Medicina (B Aires); 2002; 62(4):305-12. PubMed ID: 12325485
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Regulation of CD23 expression by Notch2 in B-cell chronic lymphocytic leukemia.
    Schwarzmeier JD; Hubmann R; Düchler M; Jäger U; Shehata M
    Leuk Lymphoma; 2005 Feb; 46(2):157-65. PubMed ID: 15621797
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Circulating levels of soluble CD23 reflect clinical and biological features of leukemic B-cell chronic lymphoproliferative disorders.
    Vinante F; Vassanelli A; Zanotti R; Nadali G; Krampera M; Vincenzi C; Morosato L; Chilosi M; Pizzolo G
    Int J Clin Lab Res; 1995; 25(4):189-94. PubMed ID: 8788546
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serum levels of TNF, IL-6 and sCD23 correlate with changes in lymphocyte count in patients with B-cell chronic lymphocytic leukaemia receiving interferon-alpha therapy.
    Jewell AP; Worman CP; Giles FJ; Goldstone AH
    Leuk Lymphoma; 1997 Jan; 24(3-4):327-33. PubMed ID: 9156662
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of alpha-interferon and steroids on CD23 expression and release in B-cell chronic lymphocytic leukemia.
    Pozzato G; de Paoli P; Franzin F; Tulissi P; Moretti M; Basaglia G; Santini GF
    Haematologica; 1994; 79(3):205-12. PubMed ID: 7926968
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.